Arcturus Therapeutics Holdings Inc.

ARCT·NASDAQ·$7.21Share Price as of 11/2·$205MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/03/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/11/25

Disclosures

8-KCurrent report09/23/26 8-KCurrent report08/25/26 8-KCurrent report08/06/26 8-KCurrent report07/02/26 8-KCurrent report06/05/26

Prospectuses and Registrations

S-3Shelf registration12/30/25 S-8Registration of securities for employees07/17/24 424B5Prospectus supplement08/07/23 S-3Shelf registration12/23/22 S-8Registration of securities for employees06/30/22

Proxies

DEF 14ADefinitive proxy04/24/26 DEF 14ADefinitive proxy04/25/25 DEF 14ADefinitive proxy04/29/24 DEF 14ADefinitive proxy05/01/23 DEFR14ADefinitive proxy (revised)05/12/22

Ownership

SC 13G/ABeneficial ownership (amended)10/29/26 SC 13G/ABeneficial ownership (amended)10/07/26 Form 4Insider transaction06/15/26 Form 4Insider transaction06/15/26 Form 4Insider transaction06/15/26

Other

NT 10-QLate filing notification (10-Q)11/12/25 CORRESPCorrespondence with the SEC12/30/22 EFFECTRequest for effectiveness12/30/22 UPLOADLetter from the SEC12/29/22 DEL AMDEL AM12/27/22